用於醫療應用的納米技術：全球市場

全球納米醫學市場預計將從 2021 年的 2426 億美元增長到 2026 年的 4935 億美元。

此外，預計 2021 年至 2026 年的複合年增長率為 15.3%。

本報告分析了全球納米醫學（用於醫療應用的納米技術）市場，概述了納米醫學及其主要應用領域、市場基本結構和主要影響因素，以及整體市場規模/CAGR。實際值（2019、2020、2021）和預測值（到 2026 年）、按類型/用途/地區劃分的詳細趨勢、市場份額結構、資本交易/業務發展的近期動向、主要公司我們正在調查的概況等。

目錄

第一章介紹

第2章總結亮點

第三章市場概述

• 含義
• 用法
• 藥物輸送
• 藥物/治療
• 活體成像
• 體外診斷
• 生物材料
• 有源植入式醫療器械（有源植入物）
• 概覽
• 醫學納米技術：納米醫學
• 納米技術
• 使用納米技術
• 醫療用途
• 環境利用
• 軍事用途
• 化妝品
• 納米技術工具
• 納米技術風險
• 市場上的納米技術
• 醫學納米技術的發展
• 脂質體
• 樹枝狀大分子
• 納米晶體
• 膠束
• 富勒烯
• 高分子納米粒子
• 納米粒子-藥物複合物
• 配體靶向納米粒子
• 陶瓷納米粒子
• 纖維素納米粒
• 納米藥物的治療用途
• 癌症的診斷和治療
• 藥物輸送
• 未來趨勢和研究潛力
• 非侵入式納米器件
• 細胞外裝置
• 細胞內裝置
• 控制組織癒合的納米機器
• 病毒消除
• 化學校正
• 新器官和四肢
• 納米技術基礎研究
• 美國
• 歐洲
• 日本
• 風險因素

第 4 章冠狀病毒感染 (COVID-19) 感染傳播的影響

• 簡介
• 出現
• COVID-19 對納米醫學的影響

第 5 章納米藥物市場

• 市場促進因素
• 市場估計/預測
• 全球納米藥物市場
• 主要產品類別
• 臨床應用市場分析

第 6 章全球納米藥物市場：按地區細分

• 簡介
• 北美
• 美國
• 加拿大
• 歐洲
• 德國
• 英國
• 法國
• 意大利
• 西班牙
• 其他歐洲國家
• 亞太地區
• 日本
• 中國
• 印度
• 其他亞太國家
• 其他地區 (RoW)

第7章競爭態勢

• 企業份額分析：全球市場
• 併購（併購）
• 合同、合作、產品發布、合作夥伴關係

第 8 章公司簡介

• ABBOTT
• ABRAXIS BIOSCIENCE (CELGENE (BRISTOL MYERS SQUIBB))
• APHIOS CORP.
• BIOFORCE NANOSCIENCES HOLDINGS INC.
• C SIXTY INC. (ARROWHEAD PHARMACEUTICALS)
• ELAN (ALKERMES)
• EYEPOINT PHARMACEUTICALS INC. (FORMERLY PSIVIDA LTD.)
• FARFIELD SCIENTIFIC (BIOLIN SCIENTIFIC AB)
• KLEINDIEK NANOTECHNIK GMBH
• LIPLASOME PHARMA APS
• MAGFORCE NANOTECHNOLOGIES
• MICROFLUIDICS CORP.
• NANOBIO CORP. (BLUEWILLOW BIOLOGICS)
• NANOBIOTIX SA
• NANOCARRIER CO. LTD.
• NANOCOPOEIA, LLC.
• NANOLOGIX INC.
• NANOMIX INC.
• NANOSPECTRA BIOSCIENCES INC.
• NANOSTRUCTURES INC.
• ORTHOVITA INC. (STRYKER CORP.)
• PFIZER INC.
• SANOFI S.A.
• STARPHARMA
• TECANGROUP LTD.
• TRANSGENEX NANOBIOTECH INC.

Highlights:

The global market for nanomedicine should grow from $242.6 billion in 2021 to $493.5 billion by 2026 with a compound annual growth rate (CAGR) of 15.3% for the period of 2021-2026.

The global market for nanopharmaceuticals should grow from $220.3 billion in 2021 to $445.2 billion by 2026 with a compound annual growth rate (CAGR) of 15.1% for the period of 2021-2026.

The global market for nanodiagnostics should grow from $22.3 billion in 2021 to $48.3 billion by 2026 with a compound annual growth rate (CAGR) of 16.7% for the period of 2021-2026.

Report Scope:

This report examines the current and forecast market potential for nanomedicine. It offers a detailed analysis of the market background, technological advancements, competitive environment, drivers and restraints, and market growth trends. This report includes market projections through 2026, detailing the market share for nanomedicine based on therapeutic areas and geography.

By therapeutic area, the nanomedicine market is segmented into anticancer, CNS products, anti-infectives, anti-inflammatories, cardiovascular, and others. By geography, the nanomedicine market has been segmented into Europe, North America, Asia-Pacific (APAC), and the Rest of the Word (ROW). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India, and China are included in the regional segments. For market estimates, data is provided for 2020 as the base year, 2021 and forecast through year-end 2026. Estimated values used are based on nanomedicine companies' total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

• 24 tables
• An overview of the global markets for nanotechnology used in medical applications
• Estimation of the market size, and analyses of the global market trends with data from 2019, 2020, 2021, with projection of CAGR through 2026
• A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications
• Information on significant products in which the nano dimension has made a significant contribution to product effectiveness
• A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine
• Identification of key market dynamics, trends, opportunities, and factors influencing the global market and highlights of the market potential for nanotechnology used in medical applications based on type, application, and region
• Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
• Company profiles of major players in the market, including Abbott, Abraxis Bioscience, Elan, Orthovita Inc., EyePoint Pharmaceuticals Inc. and Farfield Scientific Ltd.

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• What's New in This Report
• Scope of Report
• Information Sources
• Methodology
• Geographic Breakdown
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2 Summary and Highlights

• Highlights of the Market for Nanomedicine

Chapter 3 Market Overview

• Definition
• Applications
• Drug Delivery
• Drugs and Therapy
• In Vivo Imaging
• In Vitro Diagnostics
• Biomaterials
• Active Implants
• Overview
• Medical Nanotechnology: Nanomedicine
• Nanotechnology
• Nanotechnology Uses
• Medical Applications
• Environmental Applications
• Military Applications
• Cosmetics
• Nanotechnology Tools
• Risks of Nanotechnology
• Nanotechnology in the Marketplace
• Development of Nanomedical Technologies
• Liposomes
• Dendrimers
• Nanocrystals
• Micelles
• Fullerenes
• Polymeric Nanoparticles
• Nanoparticle-Drug Conjugates
• Ligand-Targeted Nanoparticles
• Ceramic Nanoparticles
• Virosome Nanoparticles
• Therapeutic Uses of Nanomedicine
• Cancer Diagnostics and Therapy
• Drug Delivery
• Future Trends and Research Possibilities
• Non-Invasive Nanodevices
• Extracellular Devices
• Intracellular Devices
• Nanomachines to Control Tissue Healing
• Eliminating Viruses
• Correcting Chemistry
• New Organs and Limbs
• Fundamental Nanotechnology Research
• U.S.
• Europe
• Japan
• Risk Factors

Chapter 4 Impact of COVID-19 Pandemic

• Introduction
• Outbreak
• Impact of COVID-19 on Nanomedicine

Chapter 5 Markets for Nanomedicine

• Market Drivers
• Market Estimates and Forecasts
• Global Nanomedicine Market
• Main Product Categories
• Market Analysis by Clinical Application

Chapter 6 Global Nanomedicine Market Breakdown by Region

• Introduction
• North America
• United States
• Canada
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Rest of Asia-Pacific
• Rest of the World (RoW)

Chapter 7 Competitive Landscape

• Global Company Share Analysis
• Mergers and Acquisitions
• Agreements, Collaborations, Product Launches and Partnerships

Chapter 8 Company Profiles

• ABBOTT
• ABRAXIS BIOSCIENCE (CELGENE {BRISTOL MYERS SQUIBB})
• APHIOS CORP.
• BIOFORCE NANOSCIENCES HOLDINGS INC.
• C SIXTY INC. (ARROWHEAD PHARMACEUTICALS)
• ELAN (ALKERMES)
• EYEPOINT PHARMACEUTICALS INC. (FORMERLY PSIVIDA LTD.)
• FARFIELD SCIENTIFIC (BIOLIN SCIENTIFIC AB)
• KLEINDIEK NANOTECHNIK GMBH
• LIPLASOME PHARMA APS
• MAGFORCE NANOTECHNOLOGIES
• MICROFLUIDICS CORP.
• NANOBIO CORP. (BLUEWILLOW BIOLOGICS)
• NANOBIOTIX SA
• NANOCARRIER CO. LTD.
• NANOCOPOEIA, LLC.
• NANOLOGIX INC.
• NANOMIX INC.
• NANOSPECTRA BIOSCIENCES INC.
• NANOSTRUCTURES INC.
• ORTHOVITA INC. (STRYKER CORP.)
• PFIZER INC.
• SANOFI S.A.
• STARPHARMA
• TECANGROUP LTD.
• TRANSGENEX NANOBIOTECH INC.

List of Tables

• Summary Table A : Global Market for Nanomedicine, by Type, Through 2026
• Summary Table B : Global Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
• Table 1 : Nanomedicine Timescale
• Table 2 : Main Nanotechnologies Used in Medicine, with Applications
• Table 3 : Marketed Liposome Nanopharmaceuticals
• Table 4 : Nanocrystal Pharmaceuticals
• Table 5 : Marketed and Developmental Products in Micelle Form
• Table 6 : Marketed Products with Nano-Enhanced Delivery
• Table 7 : European Nanocenters
• Table 8 : Marketed Nanopharmaceuticals
• Table 9 : Global Nanomedicine Market, by Type, Through 2026
• Table 10 : Global Nanopharmaceuticals Market, by Therapeutic Area, Through 2026
• Table 11 : Major Marketed Anticancer Nanopharmaceuticals
• Table 12 : Major Marketed CNS Nanopharmaceuticals
• Table 13 : Major Marketed Anti-Infective Nanopharmaceuticals
• Table 14 : Major Marketed Nanomedicines for Cardiovascular and Inflammatory Diseases
• Table 15 : Global Market for Nanomedicine, by Region, Through 2026
• Table 16 : North American Market for Nanomedicine, by Type, Through 2026
• Table 17 : North American Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
• Table 18 : European Market for Nanomedicine, by Type, Through 2026
• Table 19 : European Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
• Table 20 : Asia-Pacific Market for Nanomedicine, by Type, Through 2026
• Table 21 : Asia-Pacific Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
• Table 22 : RoW Market for Nanomedicine, by Type, Through 2026
• Table 23 : RoW Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
• Table 24 : Global Nanomedicine Market Ranking, by Company, 2020

List of Figures

• Summary Figure A : Global Market for Nanomedicine, by Type, 2019-2026
• Summary Figure B : Global Market for Nanopharmaceuticals, by Therapeutic Area, 2019-2026
• Figure 1 : Global Market Share for Nanomedicine, by Region, 2020
• Figure 2 : Abbott: Annual Revenue, 2018-2020
• Figure 3 : Abbott: Revenue Share, by Country, 2020
• Figure 4 : Abbott: Revenue Share, by Business Segment, 2020
• Figure 5 : Bristol Myers Squibb: Annual Revenue, 2018-2020
• Figure 6 : Bristol Myers Squibb: Revenue Share, by Region, 2020
• Figure 7 : Alkermes: Annual Revenue, 2018-2020
• Figure 8 : Stryker Corp.: Annual Revenue, 2018-2020
• Figure 9 : Stryker Corp.: Revenue Share, by Region, 2020
• Figure 10 : Stryker Corp.: Revenue Share, by Business Segment, 2020